drug
V-181
Phase 2updated 3mo agoby $MRK Merck & Co., Inc.
Phase 2community read0 votes
all catalysts(0)
nothing on the calendar yet
Trials studying V-181
- phase1A Study of ABBV-927 and ABBV-181, an Immunotherapy, in Participants With Advanced Solid Tumors
- phase1A Study to Determine the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of ABBV-927 With ABBV-368, Budigalimab (ABBV-181) and/or Chemotherapy in Participants With Locally Advanced or Metastatic Solid Tumors
- phase1A Study of ABT-165 in Subjects With Solid Tumors
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 9m ago
Found something off?
comments(0)
5-min edit window · permanent after that